Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.879
-0.005 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
0.876
-0.003 (-0.36%)
After-hours: Apr 28, 2026, 7:55 PM EDT
RVPH Employees
Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
14
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,418,922
Market Cap
11.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| BioLineRx | 24 |
| BioCardia | 21 |
| BioVie | 13 |
| Cellectar Biosciences | 11 |
| Aprea Therapeutics | 8 |
RVPH News
- 1 day ago - Reviva Pharmaceuticals Holdings Transcript: Study update - Transcripts
- 4 weeks ago - Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - What's Behind The Drop In Reviva Pharmaceuticals Stock? - Benzinga
- 5 weeks ago - Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewsWire
- 3 months ago - Reviva Pharmaceuticals Holdings Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit - Transcripts
- 4 months ago - Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum - GlobeNewsWire
- 4 months ago - FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Benzinga